Pictured: CSL manufacturing employee in Australia

Senior Medical Director, Global Clinical Program Lead - Immunoglobulins

Entité: CSL Behring

Catégorie d’emploi: Physicians

Famille d’emploi: Research & Medical Affairs

Type d’emploi: Full Time

Location: King of Prussia, Pennsylvania, United States

Référence de l'employeur: R-293920

CSL Behring

Description du poste

Position Overview:


The Senior Medical Director, Global Clinical Program Leader (GCPL) is a critical role within Clinical Development. The Senior GCPL is

accountable for the design and execution of the clinical strategy to support the development of a medicine, aligned with the Project Strategy Document (PSD) and the Target Product Profile (TPP). The GCPL is accountable for the strategic leadership of the Clinical Development Team (CDT) in a matrixed environment. Reports to the Global Clinical Lead (GCL).


Work Environment:


*** This is a hybrid position based onsite at any of the posted locations with a minimum of 3 days onsite weekly.  Relocation assistance and visa sponsorship are not provided.

Key Resonsibilities:


Clinical Development Team (CDT) Leadership:


  • Provides leadership and guidance to all members of the cross-functional CDT acting as the lead scientific expert for the clinical program, while ensuring appropriate functional representation in team discussions
  • accountable for the timely development and maintenance of the Clinical Development Plan (CDP) in alignment with the Program Strategy Team (PST) and Therapeutic Area Leadership Team (TALT)
  • Leads the integration of internal and external expert contributions to strategy and design of the assigned clinical program(s)
  • Maintaining alignment across critical stakeholders prior to key decision making forums (e.g. Strategic Development Committee (SDC) or Scientific and Technical Review Committee (STRC) for study outline approval)
  • Ensures that the program is conducted in alignment with CSL Behring processes and abiding by GCP and ICH regulations
  • Responsible for driving and documenting decision making within the CDT, facilitating issue resolution and escalation, as well as contingency planning

Clinical & Scientific Oversight:


  • Accountable for the clinical content for all CDT deliverables to ensure safe, efficient, timely and quality execution of assigned clinical programs
  • Ensures high quality clinical and scientific standards are met throughout all aspects of the program
  • Serves as the clinical development representative on the required cross-functional teams, including but not limited to the Study Execution Team (SET), Safety Management Team (SMT), the Benefit-Risk Assessment Team (BRAT), the Biomarker Expert Team (BET), and the Evidence and Access Strategy Team (EAST) for assigned programs
  • Develops and executes the Medical Monitoring Plan (MMP) strategy
  • Typically serves as the medical monitor for clinical trials during study conduct or provides oversight to assigned medical monitors
  • Presents results to Safety Monitoring Committee and other internal and external meetings
  • May participate or lead Due Diligence projects in support of CSL’s external innovation efforts

Document Authorship:


  • Reviews the data generated during the planning and execution of a study to gather a clinical understanding of the safety and efficacy results and the impact of the data on ongoing R&D strategies and provides support in defining the development strategy
  • “Lead Author” or “Contributing” Author for key study documents, including but not limited to: the TPP, PSD, CDP, Study Concept Scenarios, Study Outlines, the Investigator Brochure (IB), Clinical Study Protocols (CSP), Master Informed Consent Forms (ICF), Medical Monitoring Plans (MMP), Safety Review Committee (SRC)/Independent Data Monitoring Committee (IDMC) Charters, and Clinical Study Reports (CSR)
  • Leads preparations of clinical sections of relevant regulatory interaction packages including but not limited to briefing books, INDs, NDAs. BLAs, ODDs, RFIs, and routine reporting
  • Contributing author the publication strategy. Author or contributing author for abstracts, presentations, and manuscripts as appropriate

Minimum Qualifications:


  • MD, PhD or PharmD in life science/healthcare discipline expected. MD - Board Certified (or non-USA equivalent) in relevant field is preferred.
  • 5+ years of relevant clinical development experience in the pharmaceutical industry is expected including experience with study data review/evaluation
  • Clinical development industry experience with a working knowledge of pharmaceutical and regulatory development processes is essential
    Demonstrated program leadership capabilities in a matrixed environment
  • Demonstrated stakeholder management skills including risk mitigation
  • Proficient in project management terminology and processes to drive clinical development program risk mitigation strategies
  • Excellent analytical thinking and scientific/medical writing skills
  • Proficient in clinical data analysis and interpretation
  • Proven effective problem-solving skills and the ability to think critically and make informed decisions
  • Demonstrated effective communication and presentation skills
  • Proven ablility to build bridges and proactively improve cross-functional collaboration

The minimum and maximum base salary range that CSL expects to pay for this position at the Waltham, MA USA work location at the time of this posting is $317,000 - $409,000/yr. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.


#LI-HYBRID

À propos de CSL Behring

CSL Behring est un chef de file mondial en biothérapeutique, mû par sa promesse de sauver des vies. Axée sur la satisfaction des besoins des patients grâce à l'utilisation des technologies les plus récentes, la société découvre, développe et fournit des thérapies innovantes aux personnes souffrant de troubles dans les domaines thérapeutiques de l'immunologie, de l'hématologie, des maladies cardiovasculaires et métaboliques, des maladies respiratoires et de la transplantation. Nous utilisons trois plateformes scientifiques stratégiques : le fractionnement du plasma, la technologie des protéines recombinantes et la thérapie cellulaire et génique, afin de soutenir l'innovation continue et d'affiner constamment les moyens par lesquels les produits peuvent répondre aux besoins médicaux non satisfaits et aider les patients à mener une vie pleine.

CSL Behring exploite l'un des plus grands réseaux de collecte de plasma au monde, CSL Plasma. Notre société mère, CSL, dont le siège social est à Melbourne, en Australie, emploie 32 000 personnes et offre ses thérapies vitales aux populations de plus de 100 pays.

Pour en savoir plus sur CSL, CSL Behring, CSL Seqirus et CSL Vifor, visitez https://www.csl.com/ et sur CSL Plasma, visitez https://www.cslplasma.com/.

Nos avantages sociaux

Pour plus d'informations sur les avantages sociaux de CSL, visitez Comment CSL soutient votre bien-être | CSL.

Votre place est chez CSL

Chez CSL, l'inclusion et l'appartenance sont au cœur de notre mission et de notre identité. Elles alimentent notre innovation au quotidien. En célébrant nos différences et en créant une culture de curiosité et d'empathie, nous sommes en mesure de mieux comprendre nos patients et nos donneurs et d'établir des liens avec eux, de favoriser des relations solides avec nos parties prenantes et de maintenir une main-d'œuvre diversifiée qui fera progresser notre entreprise et notre industrie vers l'avenir.

Pour en savoir plus sur l'inclusion et l'appartenance, visitez https://www.csl.com/careers/inclusion-and-belonging

Employeur offrant l’égalité des chances

CSL est un employeur offrant l'égalité des chances. Si vous êtes une personne handicapée et que vous avez besoin d'un aménagement raisonnable pour une partie du processus de candidature, veuillez visiter https://www.csl.com/accessibility-statement.

Emplacement de l'emploi